Cargando…

Increased plasma DYRK1A with aging may protect against neurodegenerative diseases

Early markers are needed for more effective prevention of Alzheimer’s disease. We previously showed that individuals with Alzheimer’s disease have decreased plasma DYRK1A levels compared to controls. We assessed DYRK1A in the plasma of cognitively healthy elderly volunteers, individuals with either...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delabar, Jean M., Lagarde, Julien, Fructuoso, Marta, Mohammad, Ammara, Bottlaender, Michel, Doran, Eric, Lott, Ira, Rivals, Isabelle, Schmitt, Frederic A., Head, Elizabeth, Sarazin, Marie, Potier, Marie-Claude
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073199/ https://www.ncbi.nlm.nih.gov/pubmed/37015911 http://dx.doi.org/10.1038/s41398-023-02419-0

Ejemplares similares

Plasma DYRK1A as a novel risk factor for Alzheimer's disease
por: Janel, N, et al.
Publicado: (2014)

Modifications of the endosomal compartment in fibroblasts from sporadic Alzheimer’s disease patients are associated with cognitive impairment
por: Xicota, Laura, et al.
Publicado: (2023)

Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer’s disease
por: Janel, N, et al.
Publicado: (2017)

Green Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A
por: Guedj, Fayçal, et al.
Publicado: (2009)

Distinct amyloid and tau PET signatures are associated with diverging clinical and imaging trajectories in patients with amnestic syndrome of the hippocampal type
por: Lagarde, Julien, et al.
Publicado: (2021)

Altered age‐linked regulation of plasma DYRK1A in elderly cognitive complainers (INSIGHT‐preAD study) with high brain amyloid load
por: Delabar, Jean M., et al.
Publicado: (2020)

DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives
por: Neumann, Fernanda, et al.
Publicado: (2018)

Could tau-PET imaging contribute to a better understanding of the different patterns of clinical progression in Alzheimer’s disease? A 2-year longitudinal study
por: Lagarde, Julien, et al.
Publicado: (2023)

Early alteration of the locus coeruleus in phenotypic variants of Alzheimer’s disease
por: Olivieri, Pauline, et al.
Publicado: (2019)

Over‐expression of Dyrk1A affects bleeding by modulating plasma fibronectin and fibrinogen level in mice
por: Postic, Guillaume, et al.
Publicado: (2023)

One-carbon cycle alterations induced by Dyrk1a dosage
por: Delabar, Jean-Maurice, et al.
Publicado: (2014)

3T sodium MR imaging in Alzheimer’s disease shows stage-dependent sodium increase influenced by age and local brain volume
por: Haeger, Alexa, et al.
Publicado: (2022)

Modifications of the endosomal compartment in peripheral blood mononuclear cells and fibroblasts from Alzheimer's disease patients
por: Corlier, F, et al.
Publicado: (2015)

GSK-3β, FYN, and DYRK1A: Master Regulators in Neurodegenerative Pathways
por: Demuro, Stefania, et al.
Publicado: (2021)

DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson's disease
por: Barallobre, M J, et al.
Publicado: (2014)

Corrective effects of hepatotoxicity by hepatic Dyrk1a gene delivery in mice with intermediate hyperhomocysteinemia
por: Latour, Alizée, et al.
Publicado: (2015)

Cerebrovascular pathology in Down syndrome and Alzheimer disease
por: Head, Elizabeth, et al.
Publicado: (2017)

Impact of Donepezil on Brain Glucose Metabolism Assessed Using [(18)F]2-Fluoro-2-deoxy-D-Glucose Positron Emission Tomography Imaging in a Mouse Model of Alzheimer’s Disease Induced by Intracerebroventricular Injection of Amyloid-Beta Peptide
por: Hugon, Gaëlle, et al.
Publicado: (2022)

Molecular Signatures of Cardiac Defects in Down Syndrome Lymphoblastoid Cell Lines Suggest Altered Ciliome and Hedgehog Pathways
por: Ripoll, Clémentine, et al.
Publicado: (2012)

Distribution of microglial phenotypes as a function of age and Alzheimer's disease neuropathology in the brains of people with Down syndrome
por: Martini, Alessandra C., et al.
Publicado: (2020)

DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down Syndrome
por: Najas, Sònia, et al.
Publicado: (2015)

Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A
por: Widowati, Esti Wahyu, et al.
Publicado: (2018)

Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development
por: Laffaire, Julien, et al.
Publicado: (2009)

DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B
por: Yousefelahiyeh, Mina, et al.
Publicado: (2018)

Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B
por: Papenfuss, Marco, et al.
Publicado: (2022)

Cognitive and Behavioral Domains That Reliably Differentiate Normal Aging and Dementia in Down Syndrome
por: Harp, Jordan P., et al.
Publicado: (2021)

Emerging roles of DYRK2 in cancer
por: Tandon, Vasudha, et al.
Publicado: (2021)

DYRK1A, a Novel Determinant of the Methionine-Homocysteine Cycle in Different Mouse Models Overexpressing this Down-Syndrome-Associated Kinase
por: Noll, Christophe, et al.
Publicado: (2009)

FastGrow: on-the-fly growing and its application to DYRK1A
por: Penner, Patrick, et al.
Publicado: (2022)

Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition
por: Blom, Kristin, et al.
Publicado: (2019)

The Omnipresence of DYRK1A in Human Diseases
por: Deboever, Estelle, et al.
Publicado: (2022)

CEP97 phosphorylation by Dyrk1a is critical for centriole separation during multiciliogenesis
por: Lee, Moonsup, et al.
Publicado: (2021)

Imaging the aging brain: study design and baseline findings of the SENIOR cohort
por: Haeger, Alexa, et al.
Publicado: (2020)

Characterization of the initial complaint and care pathways prior to diagnosis in very young sporadic Alzheimer’s disease
por: Olivieri, Pauline, et al.
Publicado: (2021)

Research attitudes in families of individuals with Down syndrome: importance for clinical trials
por: Lott, Ira T., et al.
Publicado: (2022)

Mirk/dyrk1B Kinase in Ovarian Cancer
por: Friedman, Eileen
Publicado: (2013)

Ocular Phenotype Associated with DYRK1A Variants
por: Méjécase, Cécile, et al.
Publicado: (2021)

Discovery and Characterization of Selective and Ligand-Efficient DYRK Inhibitors
por: Henderson, Scott H., et al.
Publicado: (2021)

Functional Roles of DYRK2 as a Tumor Regulator
por: Mochimaru, Yuta, et al.
Publicado: (2023)

Aging and Down Syndrome
por: Head, Elizabeth, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_s95r0m6r4lb1l47ja5euh5btvf